The PET and the pendulum

Annals of Internal Medicine

Volumn 151, Issue 4, 2009, Pages 279-280

  Margolis, Mitchell L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HISTOPATHOLOGY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDICAL PRACTICE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TUMOR BIOPSY; HUMAN; LUNG TUMOR; METHODOLOGY; NOTE; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69149098259     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-151-4-200908180-00134     Document Type: Editorial

References (17)

1. Weil MH. The assault on the Swan-Ganz catheter: a case history of constrained technology, constrained bedside clinicians, and constrained monetary expenditures. Chest. 1998;113:1379-1386 [PMID: 9596322]
2. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059-2073 [PMID: 12759479]
3. Wan IY, Toma TP, Geddes DM, Snell G, Williams T, Venuta F, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest. 2006;129:518-526 [PMID: 16537847]
4. Maziak DE, Darling GE, Inculet RI, Gulenchyn KY, Driedger AA, Ung YC, et al. Positron emission tomography in staging early lung cancer. A randomized trial. Ann Intern Med. 2009;151:221-228
5. van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002;359:1388-1393 [PMID: 11978336]
6. Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol. 2004;22:2357-2362 [PMID: 15197196]
7. Herder GJ, Kramer H, Hoekstra OS, Smit EF, Pruim J, van Tinteren H, et al; POORT Study Group. Traditional versus up-front [18F] fluorodeoxyglucose- positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol. 2006; 24:1800-1806 [PMID: 16567772] (Pubitemid 46638976)
8. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500-2507 [PMID: 12815135] (Pubitemid 36706537)
9. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology. 2003;229:526-533 [PMID: 14512512] (Pubitemid 37310842)
10. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78: 1017-23; discussion 1017-1023 [PMID: 15337041] (Pubitemid 39164825)
11. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology. 2005;236:1011-1019 [PMID: 16014441] (Pubitemid 41170866)
12. Joshi SC, Pant I, Hamzah F, Kumar G, Shukla AN. Integrated positron emission tomography/computed tomography fusion imaging: an emerging gold standard in lung cancer. Indian J Cancer. 2008;45:137-141 [PMID: 19112200]
13. Subedi N, Scarsbrook A, Darby M, Korde K, Mc Shane P, Muers MF. The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. Lung Cancer. 2009;64:301-307 [PMID: 19004519]
14. Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, et al. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer. J Nucl Med. 2008;49:1606-1612 [PMID: 18794269]
15. Herth FJ, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133:887-891 [PMID: 18263680]
16. Carnochan FM, Walker WS. Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients. Eur J Cardiothorac Surg. 2009;35:781-4; discussion 784-785 [PMID: 19272791]
17. Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, et al. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Acta Radiol. 2008;49:995-1004. [PMID: 18651256]